Cartesian Therapeutics OverviewCartesian Therapeutics Net Income
Profitability analysis for RNAC.
Quarterly Net Income
-$39.18M
↓ 121.24% YoY
As of Mar 2026
Annual Net Income (TTM)
-$151.77M
↓ 39.28% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...